In the News

1827 News Items found
In the Clinic
A close-up of fingers inserting acupuncture needles into skin
Acupuncture May Ease ‘Brain Fog’ in Breast Cancer Survivors, Trial Shows
A phase 2 randomized clinical trial at MSK has found that acupuncture can improve cognitive abilities in breast cancer survivors experiencing "brain fog."
Article
MSK hematologist-oncologist Dr. Lia Palomba
FDA Approves Marginal Zone Lymphoma CAR T Cell Treatment
Read about a new CAR T cell therapy now approved for marginal zone lymphoma (MZL).
Article
MSK medical oncologist Komal Jhaveri.
Imlunestrant With or Without Abemaciclib Effective in Treating ER+, HER2- Advanced Breast Cancer That Resists Standard Therapy
Read about a new treatment for people with some ER+, HER2- advanced breast cancers.
MSK medical oncologist and bladder cancer specialist Jonathan Rosenberg
Bladder Cancer Therapy Enfortumab Vedotin (Padcev) Approved by FDA for More Patients
A powerful therapy called an antibody-drug conjugate has been approved by the FDA for more people with bladder cancer.
Article
MSK medical oncologist and breast cancer specialist Dr. Komal Jhaveri.
Antibody-Drug Conjugate for Endocrine-Refractory and Chemotherapy Naive HR+, HER2- Breast Cancer
Read about an antibody-drug conjugate treatment for HR+, HER2- breast cancer.
MSK multiple myeloma specialist Urvy Shah
Diets for MGUS, Smoldering Myeloma, and Multiple Myeloma: Q&A With MSK Cancer and Nutrition Experts
Learn how eating a plant-based diet may prevent MGUS and smoldering myeloma from developing into multiple myeloma, according to MSK research.
Dr. Urvi Shah is seen smiling at the camera.
MSK Research Reveals Connection Between Diet and Cancer
Learn more about how a clinical trial at MSK revealed important connections between the foods we eat and our cancer risk.
Clinical Update
MSK cellular therapist Heather Landau
CAR T Cell Therapy for Light Chain (AL) Amyloidosis Achieves Strong Results
Read about a CAR T cell therapy that appears effective against light chain (AL) amyloidosis.
Article
MSK myeloma specialist and cellular therapist Saad Usmani, MD
New Extramedullary Myeloma Treatment With Bispecific Antibodies Improves Survival Dramatically
Read about a new treatment combining bispecific antibodies that is effective against extramedullary myeloma.
Michael with his granddaughter on a boat
New Treatment for Relapsed Follicular Lymphoma Approved by FDA After MSK-Led Clinical Trial
A phase 3 trial led by MSK showed that adding epcoritamab to traditional treatment for follicular lymphoma benefits patients. Epcoritamab received FDA approval based on the findings.